Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Serous Tumor of Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05057715
What this trial is testing

HuCART-meso + VCN-01 in Pancreatic and Ovarian Cancer

Who this might be right for
Pancreatic CancerSerous Ovarian Cancer
University of Pennsylvania 13
Not applicableStudy completedNCT01080521
What this trial is testing

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

Who this might be right for
Cognitive Side Effects of Cancer TherapyMalignant Ovarian Epithelial TumorOvarian Brenner Tumor+51 more
Gynecologic Oncology Group 247
Early research (Phase 1)Active Not RecruitingNCT02142803
What this trial is testing

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

Who this might be right for
Adult GlioblastomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+21 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00928642
What this trial is testing

Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cancer
Henry M. Jackson Foundation for the Advancement of Military Medicine 8
Not applicableNot Yet RecruitingNCT07687602
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity of Mirvetuximab Soravtansine-gynx in Adults With Folate Receptor-Alpha Positive, Platinum-Resistant Ovarian Cancer in a Real-World Setting

Who this might be right for
Folate Receptor-Alpha Positive Platinum-Resistant High-Grade Serous Epithelial Ovarian CancerFolate Receptor-Alpha Positive Platinum-Resistant Fallopian Tube CancerFolate Receptor-Alpha Positive Platinum-Resistant Primary Peritoneal Cancer
AbbVie
Testing effectiveness (Phase 2)Ended earlyNCT02107378
What this trial is testing

Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma

Who this might be right for
Epithelial Ovarian Carcinoma
SOTIO a.s. 22
Not applicableNot Yet RecruitingNCT06726330
What this trial is testing

Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer

Who this might be right for
Tubo-ovarian CarcinomaHigh-grade Serous CarcinomaPrimary Peritoneal Carcinoma Stage III+2 more
Centre Oscar Lambret 1,100
Testing effectiveness (Phase 2)UnknownNCT06055348
What this trial is testing

SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer

Who this might be right for
Serous Ovarian CancerAdvanced Ovarian Cancer
Biocity Biopharmaceutics Co., Ltd. 112
Early research (Phase 1)Study completedNCT02262455
What this trial is testing

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+1 more
Santa Maria Biotherapeutics 32
Not applicableStudy completedNCT05741554
What this trial is testing

Low Grade Serous Ovarian Carcinoma and Uterine Involvement : Should Hysterectomy be the Rule

Who this might be right for
Serous Ovarian CarcinomaLow Grade Serous Ovarian Carcinoma
Hospices Civils de Lyon 28
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Not applicableEnded earlyNCT03606486
What this trial is testing

Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer

Who this might be right for
High Grade Ovarian Serous AdenocarcinomaStage III Ovarian Cancer AJCC v8Stage IIIA Ovarian Cancer AJCC v8+7 more
University of Washington 52
Early research (Phase 1)Study completedNCT03586661
What this trial is testing

Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Deleterious BRCA1 Gene MutationDeleterious BRCA2 Gene MutationEndometrial Adenocarcinoma+8 more
M.D. Anderson Cancer Center 31
Not applicableLooking for participantsNCT04794322
What this trial is testing

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsOvarian Epithelial CarcinomaFallopian Tube Neoplasms+12 more
Massachusetts General Hospital 250
Large-scale testing (Phase 3)Active Not RecruitingNCT02502266
What this trial is testing

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Serous Adenocarcinoma+12 more
National Cancer Institute (NCI) 582
Testing effectiveness (Phase 2)UnknownNCT06377267
What this trial is testing

Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)

Who this might be right for
Ovarian Cancer
Vall d'Hebron Institute of Oncology 100
Not applicableStudy completedNCT05490407
What this trial is testing

Role of the ATP7A Transporter in Ovarian Cancer

Who this might be right for
Gynecologic CancerOvarian CancerHigh Grade Serous Carcinoma+1 more
University Medical Centre Ljubljana 40
Early research (Phase 1)Looking for participantsNCT06976892
What this trial is testing

Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer

Who this might be right for
High Grade Serous Ovarian Cancer
Institute of Cancer Research, United Kingdom 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT02345265
What this trial is testing

Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer

Who this might be right for
Fallopian Tube CarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Serous Adenocarcinoma+6 more
National Cancer Institute (NCI) 70
Early research (Phase 1)Active Not RecruitingNCT03875820
What this trial is testing

Phase I Trial of Defactinib and VS-6766.

Who this might be right for
NSCLCLow Grade Serous Ovarian CancerEndometrioid Carcinoma+1 more
Institute of Cancer Research, United Kingdom 87
Next Page
69